Parents and pediatricians navigate the complexities of neurodiversity, emphasizing the need for open communication and better resources for child development.

The FDA approves gardenia (genipin) blue as a natural food color, enhancing options for manufacturers and supporting the shift away from synthetic dyes.

A study reveals declining US neonatal mortality overall, yet highlights rising deaths from fetal malnutrition, emphasizing ongoing disparities in neonatal health outcomes.

A look back at the most important FDA approvals, clinical research, and expert perspectives shaping pediatric health care in the first half of 2025.

A newly-published study identified specific groups of higher-risk children that could benefit most from monoclonal antibodies.

A pro-inflammatory maternal diet during pregnancy was linked to a 16% higher risk of type 1 diabetes in offspring, Danish cohort study finds.

The FDA accepted Eton Pharmaceuticals' NDA for ET-600 for pediatric arginine vasopressin deficiency, with a target action date in February of 2026.

The American Academy of Pediatrics warns families to avoid home fireworks and offers safer alternatives to prevent injuries, especially in young children.

Multiple medical societies, including the American Academy of Pediatrics (AAP), are suing the US Department of Health and Human Services (HHS) and Secretary Robert F. Kennedy Jr. in an effort to ...

A roundup of the most impactful FDA approvals in pediatric health from January through June 2025, spanning diagnostics, therapeutics, and at-home care.

On July 7, 2025, the FDA approved KalVista Pharmaceuticals' novel plasma kallikrein inhibitor sebetralstat (Ekterly) to treat acute attacks of hereditary angioedema (HAE) in adult and pediatric ...

A week into July 2025, the total reported cases in the United States have surpassed the peak of 1274 cases recorded for all 2019. As of July 4, 2025, there were 1277 measles cases reported in the ...